Earnings

MAIA Biotechnology Q2 EPS $(0.13) Misses $(0.11) Estimate

Aug 10, 2026 · 09:06 AM ET· updated 1h ago

MAIA Biotechnology (AMEX:MAIA) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.11) by 18.18 percent. This is a 27.78 percent increase over losses of $(0.18) per share

Why It Matters

MAIA lost more money per share than experts predicted, which is disappointing news. But the company is actually losing *less* money than it did a year ago, which shows it's moving in a better direction.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

MAIA1.40

-0.02 (-1.76%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.